These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 12416541)
1. Adenovirus-mediated gene transfer of B7.1 induces immunological anti-tumor effects in a murine brain tumor. Morioka J; Kajiwara K; Yoshikawa K; Ideguchi M; Uchida T; Ohmoto Y; Suzuki M J Neurooncol; 2002 Oct; 60(1):13-23. PubMed ID: 12416541 [TBL] [Abstract][Full Text] [Related]
2. Vaccine therapy for murine glioma using tumor cells genetically modified to express B7.1. Morioka J; Kajiwara K; Yoshikawa K; Ideguchi M; Uchida T; Suzuki M Neurosurgery; 2004 Jan; 54(1):182-9; discussion 189-90. PubMed ID: 14683556 [TBL] [Abstract][Full Text] [Related]
3. Induction of effective antitumor immunity in a mouse brain tumor model using B7-1 (CD80) and intercellular adhesive molecule 1 (ICAM-1; CD54) transfection and recombinant interleukin 12. Joki T; Kikuchi T; Akasaki Y; Saitoh S; Abe T; Ohno T Int J Cancer; 1999 Aug; 82(5):714-20. PubMed ID: 10417770 [TBL] [Abstract][Full Text] [Related]
4. Immune gene therapy of experimental mouse brain tumor with adenovirus-mediated gene transfer of murine interleukin-4. Yoshikawa K; Kajiwara K; Ideguchi M; Uchida T; Ito H Cancer Immunol Immunother; 2000 Apr; 49(1):23-33. PubMed ID: 10782863 [TBL] [Abstract][Full Text] [Related]
5. Human glioma cells transformed by IGF-I triple helix technology show immune and apoptotic characteristics determining cell selection for gene therapy of glioblastoma. Ly A; Duc HT; Kalamarides M; Trojan LA; Pan Y; Shevelev A; François JC; Noël T; Kane A; Henin D; Anthony DD; Trojan J Mol Pathol; 2001 Aug; 54(4):230-9. PubMed ID: 11477137 [TBL] [Abstract][Full Text] [Related]
6. Purification of antigenic peptide from murine hepatoma cells recognized by Class-I major histocompatibility complex molecule-restricted cytotoxic T-lymphocytes induced with B7-1-gene-transfected hepatoma cells. Nakatsuka K; Sugiyama H; Nakagawa Y; Takahashi H J Hepatol; 1999 Jun; 30(6):1119-29. PubMed ID: 10406192 [TBL] [Abstract][Full Text] [Related]
7. Replication-deficient adenovirus-mediated transfer of B7-1 (CD80) cDNA induces anti-tumour immunity in isolated human lung cancer. Iwakami SI; Setoguchi Y; Saijo Y; Azuma M; Fukuchi Y Respirology; 2001 Jun; 6(2):135-44. PubMed ID: 11422893 [TBL] [Abstract][Full Text] [Related]
8. GM-CSF and B7-1 (CD80) co-stimulatory signals co-operate in the induction of effective anti-tumor immunity in syngeneic mice. Sumimoto H; Tani K; Nakazaki Y; Tanabe T; Hibino H; Hamada H; Azuma M; Asano S Int J Cancer; 1997 Nov; 73(4):556-61. PubMed ID: 9389572 [TBL] [Abstract][Full Text] [Related]
9. Effect of B7.1-transfected human colon cancer cells on the induction of autologous tumour-specific cytotoxic T cells. Miyazono Y; Kamogawa Y; Ryo K; Furukawa T; Mitsuhashi M; Yamauchi K; Kameoka T; Hayashi N J Gastroenterol Hepatol; 1999 Oct; 14(10):997-1003. PubMed ID: 10530496 [TBL] [Abstract][Full Text] [Related]
10. Combinational immunotherapy for established tumors with engineered tumor vaccines and adenovirus-mediated gene transfer. Xiang J; Chen Y; Moyana T Cancer Gene Ther; 2000 Jul; 7(7):1023-33. PubMed ID: 10917205 [TBL] [Abstract][Full Text] [Related]
11. T-helper- and accessory-cell-independent cytotoxic responses to human tumor cells transfected with a B7 retroviral vector. Döhring C; Angman L; Spagnoli G; Lanzavecchia A Int J Cancer; 1994 Jun; 57(5):754-9. PubMed ID: 7515023 [TBL] [Abstract][Full Text] [Related]
12. In situ expression of soluble B7-1 in the context of oncolytic herpes simplex virus induces potent antitumor immunity. Todo T; Martuza RL; Dallman MJ; Rabkin SD Cancer Res; 2001 Jan; 61(1):153-61. PubMed ID: 11196154 [TBL] [Abstract][Full Text] [Related]
13. B7.1 expression by the weakly immunogenic F98 rat glioma does not enhance immunogenicity. Paul DB; Barth RF; Yang W; Shen GH; Kim J; Triozzi PL Gene Ther; 2000 Jun; 7(12):993-9. PubMed ID: 10871746 [TBL] [Abstract][Full Text] [Related]
14. [Immunoprotective effect of IL-2 and B7-1 gene co-transfected liver cancer vaccines on hepatocarcinogenesis in mice]. Ge N; Ye S; Liu Y; Tang Z Zhonghua Gan Zang Bing Za Zhi; 2002 Dec; 10(6):417-20. PubMed ID: 12502440 [TBL] [Abstract][Full Text] [Related]
15. T cell costimulation by B7/BB1 induces CD8 T cell-dependent tumor rejection: an important role of B7/BB1 in the induction, recruitment, and effector function of antitumor T cells. Ramarathinam L; Castle M; Wu Y; Liu Y J Exp Med; 1994 Apr; 179(4):1205-14. PubMed ID: 7511683 [TBL] [Abstract][Full Text] [Related]
16. Adenoviral-mediated transfer of human wild-type p53, GM-CSF and B7-1 genes results in growth suppression and autologous anti-tumor cytotoxicity of multiple myeloma cells in vitro. Ren SP; Wu CT; Huang WR; Lu ZZ; Jia XX; Wang L; Lao MF; Wang LS Cancer Immunol Immunother; 2006 Apr; 55(4):375-85. PubMed ID: 16001164 [TBL] [Abstract][Full Text] [Related]
17. A reassessment of the role of B7-1 expression in tumor rejection. Wu TC; Huang AY; Jaffee EM; Levitsky HI; Pardoll DM J Exp Med; 1995 Nov; 182(5):1415-21. PubMed ID: 7595212 [TBL] [Abstract][Full Text] [Related]
18. Tumor cells cotransfected with interleukin-7 and B7.1 genes induce CD25 and CD28 on tumor-infiltrating T lymphocytes and are strong vaccines. Cayeux S; Beck C; Aicher A; Dörken B; Blankenstein T Eur J Immunol; 1995 Aug; 25(8):2325-31. PubMed ID: 7545119 [TBL] [Abstract][Full Text] [Related]
19. Anti-gastric cancer active immunity induced by FasL/B7-1 gene-modified tumor cells. Zheng SY; Li DC; Zhang ZD; Zhao J; Ge JF World J Gastroenterol; 2005 Jun; 11(21):3204-11. PubMed ID: 15929168 [TBL] [Abstract][Full Text] [Related]
20. Therapeutic anti-tumor response induced with epitope-pulsed fibroblasts genetically engineered for B7.1 expression and IFN-gamma secretion. Kim TS; Chung SW; Kim SH; Kang SN; Kang BY Int J Cancer; 2000 Aug; 87(3):427-33. PubMed ID: 10897050 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]